Sullivan Lara
Related Filers (2)
Other (4)
144
Thursday, 9/14/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 9/13/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 9/12/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 9/11/2023
Filing for proposed sale of securities under Rule 144
Ownership (14)
4
Wednesday, 9/13/2023
Pyxis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/8/2023
Pyxis Oncology, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 4/4/2023
Pyxis Oncology, Inc.: Major Shareholders
4
Tuesday, 3/28/2023
Pyxis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2023
Pyxis Oncology, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 5/23/2022
Pyxis Oncology, Inc.: Major Shareholders
4
Friday, 4/15/2022
Pyxis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2022
Pyxis Oncology, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 10/22/2021
Pyxis Oncology, Inc.: Major Shareholders
4
Tuesday, 10/12/2021
Pyxis Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/7/2021
Pyxis Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/7/2019
REXAHN PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 3/1/2019
REXAHN PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
3
Friday, 3/1/2019
REXAHN PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities